N-acetylcysteine (NAC) is a mucolytic agent with antioxidant and anti-inflammatory
properties. The respiratory syncytial virus (RSV) is one of the most important etiological …

Objective. Respiratory syncytial virus (RSV) infection is an important cause of hospitalization
of children worldwide, leading to significant morbidity and mortality. RSV infection leads to …

Abstract Background and Objectives: Air pollutants can induce and incite airway diseases
such as asthma. N-acetylcysteine (NAC) affects signaling pathways involved in apoptosis …

N-acetylcysteine (NAC) is a mucolytic drug commonly used as an adjuvant therapy in
patients with respiratory conditions associated with excessive mucus production. NAC also …

N-acetylcysteine (NAC) is widely used because of its mucolytic effects, taking part in the
therapeutic protocols of cystic fibrosis. NAC is also administered as an antidote in …

64% of chronic obstructive pulmonary disease (COPD) exacerbations are caused by
respiratory infections including influenza (strains A and B) and respiratory syncytial virus …

Abstract N-Acetyl-l-cysteine (NAC) acts as a precursor of the tripeptide glutathione (GSH),
one of the principal cell mechanisms for reactive oxygen species (ROS) detoxification …

This article explores current evidence on the role of oxidative stress in viral infections, and
on the use of antioxidant drugs as adjunctive treatment. MEDLINE/PubMed was searched …

Keywords: A549 cells, alveolar epithelial cell, cytotoxicity, N-acetylcysteine, RSV infection
INTRODUCTION Respiratory syncytial virus (RSV; genus Orthopneumovirus, family …

The thiol reducing agent N-acetylcysteine (NAC) is commonly used as an “antioxidant” in
studies examining gene expression, signaling pathways, and outcome in acute and chronic …